Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure – Clinical Research Sites (U24 Clinical Trial Not Allowed)
Forecasted
NIH seeks to support clinical research sites for NeuroNEXT to advance neurological disorder trials and biomarker studies by providing infrastructure and collaboration opportunities.
Funder: National Institutes of Health
Due Dates (Anticipated): November 2027 (anticipated)
Funding Amounts: Not yet specified; expected to support multiple network clinical research sites for multi-year infrastructure projects.
Summary: Supports clinical research sites as part of the NeuroNEXT network to accelerate clinical trials and biomarker validation studies in neurological disorders.
Key Information: This is a forecasted opportunity; applications are not yet being solicited.
Description
The National Institute of Neurological Disorders and Stroke (NINDS) at the NIH anticipates continuing support for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) infrastructure. This program funds clinical research sites that participate in NeuroNEXT, which conducts multi-site clinical trials and biomarker validation studies for neurological disorders affecting both adults and children. The aim is to provide a high-quality, collaborative infrastructure that accelerates the development of effective neurotherapeutics and advances clinical research through rigorous evidence generation. This notice serves to give potential applicants ample time to plan collaborations and prepare responsive applications.
